Opendata, web and dolomites

CAPSULTEK SIGNED

Unlocking the potential of thermo-sensitive bioactive ingredients through a disruptive encapsulation method

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CAPSULTEK project word cloud

Explore the words cloud of the CAPSULTEK project. It provides you a very rough idea of what is the project "CAPSULTEK" about.

assuring    formulation    megatrend    global    encapsulated    pressurized    50    bioinicia    bold    capsultek    assisted    revenue    protect    entail    until    acceptance    prone    besides    usually    model    molecule    industry    nutritional    foods    bioactive    extend    launched    line    easily    massively    additional    electrospraying    claim    bioavailability    stability    basic    concentration    nanoencapsulation    energy    stated    lasting    probiotics    wise    encapsulation    reduce    volumes    markets    temperature    vitamins    intensive    profit    industrial    2022    started    portfolio    moment    fifth    consumers    oxidation    functional    vulnerable    encapsulate    experts    food    companies    demo    industries    commercialization    optimize    business    shelf    ingredients    grow    living    foresee    integrity    market    eager    plant    matrix    scalable    certain    adding    room    gas    deploying    readiness    omega    introducing    thermolabile    added    innovative    40    ph    health    first    industrially    damaging    designed    prototype    benefits    life   

Project "CAPSULTEK" data sheet

The following table provides information about the project.

Coordinator
BIOINICIA SL 

Organization address
address: CALLE ALGEPSER 65 PUERTA 3
city: PATERNA
postcode: 46980
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 985˙062 €
 EC max contribution 689˙543 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOINICIA SL ES (PATERNA) coordinator 689˙543.00

Map

 Project objective

Functional foods provide additional health benefits beyond its nutritional value by adding certain bioactive ingredients to its basic formulation, like Omega-3, probiotics or vitamins. They are massively consumed, being a long-lasting megatrend in food industry, started in the 80’s, and currently living its best moment. Their generated revenue will grow by 50 % until 2022. 1 out of 4 new food products launched have a functional claim. So, global food industries are eager to increase their functional food products portfolio due to its high consumers’ acceptance, potential for deploying new markets, and higher added value. However, most of these bioactive ingredients are easily vulnerable (prone to oxidation, thermolabile…), so, there is a challenge in assuring their integrity and bioavailability when introducing them in food products (complex matrix!). To protect them they are usually encapsulated. Most encapsulation methods work at high temperature damaging the ingredients. Moreover, most methods are energy-intensive, and entail high production costs. In Bioinicia we are experts in nanoencapsulation, and we have developed CAPSULTEK: an innovative own-developed technology called Electrospraying Assisted by Pressurized Gas of which we have a 1 t/year prototype. With our technology we can work at room temperature, encapsulate any kind of molecule, enhance its stability and extend its shelf-life. Besides, industrially-wise, we can scale it up to reach industrial volumes, to reduce encapsulation costs by 40% and to increase concentration bioactive ingredients by 50%. We need Ph.2 to reach market readiness. We will build an industrial demo plant of 10 tonnes/year and will optimize the processing parameters for Omega-3 and probiotics. We have designed a bold and effective highly scalable business model to make the most of CAPSULTEK. First-line food companies have already stated their interest on it, and we foresee an 8 M€ profit by the fifth year of its commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAPSULTEK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CAPSULTEK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More  

Manuback (2019)

MANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods

Read More